• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number SP-101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Patient Problem/Medical Problem (2688)
Event Date 12/11/2017
Event Type  Injury  
Manufacturer Narrative
No components from the venaseal closure system kit was received for evaluation.No photographic images of the patient¿s symptoms were received for evaluation.Four photographic images of sonogram images were provided.The images show a possible thrombosis/adhesive mass protruding into the sapheno-femoral junction.Customer experience is confirmed based on photographs provided.
 
Event Description
It was reported that the patient received vena seal treatment of the left and right great saphenous vein (gsv).Procedure was completed as per ifu and standard protocols.Catheter tip was located 5cm caudal to the sapheno-femoral junction (sfj) prior to initial delivery of the adhesive.Volumes used were reported as 1.5cc in left gsv <(>&<)> 1.2cc in right gsv.The total lengths treated were reported as 38cm left gsv, 32cm in right gsv.It was reported that the vein closed.On ultrasound check, 2 days post procedure, it could be seen that the glue protruded past the sfj.It is reported that the patient was prescribed xarelto due to protrusion of the glue.The patient is reported to be doing well.Follow-up information indicates the patient had a mild inflammatory response, however follow-up ultrasound indicates that the protrusion has retracted distal to the sfj.The physician plans to continue with xarelto for a full course of 12 weeks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7180870
MDR Text Key96929762
Report Number9612164-2018-00051
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 01/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSP-101
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/13/2017
Initial Date FDA Received01/10/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
Patient Weight81
-
-